LBVH0101 (Hib vaccine)

BIOLOGICAL2 trials

Sponsors

LG Life Sciences

Conditions

Infectious Disease by Haemophilus Influenzae Type b

Phase 3

Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

CompletedNCT01019772

LG Life SciencesInfectious Disease by Haemophilus Influenzae Type b

Start: 2007-07-31End: 2008-08-31Updated: 2009-11-25

Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

CompletedNCT01251133

LG Life SciencesInfectious Disease by Haemophilus Influenzae Type b

Start: 2008-07-31End: 2009-03-31Updated: 2010-12-01

Related Papers

Immunogenicity and safety of LBVH0101, a new Haemophilus influenzae type b tetanus toxoid conjugate vaccine, compared with Hiberix™ in Korean infants and children: a randomized trial.

2012-01-134 citations